Refine by
Bioinformatics Suppliers Serving Belgium
106 companies found
based inChicago, ILLINOIS (USA)
Igenbio, Inc. develops genome analysis products and services for the life science industry. Our scientists have broad experience in both in silico and wet lab sequencing, research and development with more than 100 relevant publications in these ...
Quickly and accurately analyze your samples with Igenbio’s expert sequencing services. Both Long and short read platforms available such as Illumina, PacBio, and Oxford Nanopore. Proximity Ligation Hi-C Sequencing for Genome Scaffolding. ...
based inIselin, NEW JERSEY (USA)
Excelra (formally Excelra Knowledge Solutions), established in 2016, is a dynamic informatics company focused on accelerating drug discovery and development through advanced data analytics and integrative informatics services. The organization ...
Our integrated IT services and bioinformatics expertise accelerate drug discovery and improve patient outcomes through bespoke scientific application ...
based inSeongnam-si, SOUTH KOREA
LISCure Biosciences Provides Novel Therapeutics to Patients with Refractory Diseases Using the LMT Platform. LISCure is developing the world’s first injectable immuno-oncology program using non-pathogenic microorganisms. We focus on the development ...
based inEpalinges, SWITZERLAND
At Alithea Genomics we are committed to developing solutions that simplify and streamline the generation of 'big RNA data', which we believe will constitute the foundation of tomorrow's research and medicine. Our technologies enable our clients to ...
based inSeoul, SOUTH KOREA
We detect and analyze genomic profile of tumor DNA with a single draw of blood. With this comprehensive profile, we provide personalized and optimized analysis information that can be utilized in therapy selection and monitoring. Ultimately, we ...
The AlphaLiquid® platform enables enhanced safety, speed and efficiency in clinical trials for drug ...
based inMontpellier, FRANCE
SeqOne Genomics is a startup based in Montpellier in the South of France, founded in 2017. The company develops state-of-the-art genomics analysis tools for clinical applications in the fields of cancer and rare diseases. Its flagship product, ...
Genetic cancer analyses are particularly challenging due to the huge number of de novo variants and the need to combine DNA and RNA data in some cases. This requires a unique set of interpretation tools and specifically tuned ...
based inMunich, GERMANY
The technological progress made in biomedical research has radically changed the view to new treatment strategies. Modern genetic technologies can deliver disease-relevant targets but are insufficient to refill the empty drug discovery pipeline. We ...
We offer several RNA-Sequencing and follow-up bioinformatics services using Illumina and Ion Torrent platforms. Our library preparation methods are customisable based on the needs of your ...
based inWoodland Hills, CALIFORNIA (USA)
EntroGen offers end-to-end molecular diagnostic solutions by providing hardware, reagents and software. Starting from automated nucleic acid extraction and culminating in genomic interpretation with proprietary software embedded for key decision ...
EntroGen NGS Targeted Hotspot Panel is a comprehensive pan-cancer assay designed to detect clinically relevant hotspot mutations in solid tumors. Utilizing a robust next-generation sequencing (NGS) platform, labs are able to simultaneously analyze ...
based inCopenhagen, DENMARK
Cmbio specializes in advancements in microbiome science and multi-omics research, primarily focused on human, animal, and planetary health. With a team of over 100 experts in microbiology, bioinformatics, metabolomics, molecular biology, and data ...
Unlock deeper insights into microbial communities with our specialized Long-Read Metagenomics services. Utilizing long-read sequencing with Oxford Nanopore Technologies (ONT), we provide highly contiguous assemblies and high-quality ...
based inSeoul, SOUTH KOREA
NGS industries are rapidly evolving and our customers are in greater need of technical support in various research fields and markets. Just like a chameleon utilizing its colored pigments and crystals to adapt to its surroundings, we proactively ...
“Unlike Whole Genome Sequencing, Targeted Sequencing is a technique that selectively analyzes specific regional sequences of genomes.” Our Target Enrichment Panel uses hybridization-based capture technology to enable the core process of ...
based inState College, PENNSYLVANIA (USA)
SoftGenetics, LLC specializes in the development of genetic analysis tools for both research and diagnostic ...
NextGENe software runs on a Windows® Operating System, which provides a biologist-friendly ‘point & click’ interface. It does not require scripting or other bioinformatics support, which are often required when ...
based inGuildford, UNITED KINGDOM
Datar Cancer Genetics is a leader in developing blood-based diagnostics that can detect cancer early, offer non-invasive investigations for better treatment options, and track the progression of the disease or its recurrence. We believe that ...
based in, MASSACHUSETTS (USA)
Thermo Scientific instruments, equipment, software, services and consumables empower scientists to solve for complex analytical challenges in pharmaceutical, biotechnology, academic, government, environmental and industrial research, as well as the ...
based inParis, FRANCE
Biogemma is a European plant biotechnology company founded in 1997 by seed companies and French field crop producers. Its original mission was to create new genetic variability via GM traits to be exploited by its shareholding companies. With the ...
Biogemma is built around 4 core platforms in 4 species, and an upstream technology ...
based inNorwich, UNITED KINGDOM
We are a passionate and skilled drug discovery and development biotech team developing an innovative new class of oligonucleotide antimicrobial agents. Procarta is currently working on lead optimisation for its first product, a narrow-spectrum agent ...
Proprietary nanoparticles deliver an oligonucleotide inside the bacterial pathogen. The oligonucleotide acts as a Transcription Factor Decoy (TFD): it contains the binding site of a transcription factor that controls a large set of genes required ...
based inPune, INDIA
ArrayGen Technologies Pvt Ltd is a Genomics service provider company with wide array of expertise in Genomics algorithm development, next generation sequencing(NGS), microarray, CADD and Bioinformatics services. Also, involved in various services in ...
ArrayGen offers a range of Next Generation Sequencing (NGS) data analysis for disease association studies, cancer genomics, personalized medicine, agriculture biotechnology and life sciences to help researchers derive meaningful conclusions from ...
based inShirley, NEW YORK (USA)
Creative Biogene provides kits, reagents, and services that help researchers explore questions about gene discovery, regulation, and function. Creative Biogene holds a leadership position in the global market and is committed to improving the human ...
With the development of microbiology, an increasing number of data needs to be collected, sorted, analyzed, and applied. At the same time, bioinformatics and sequencing technologies have flourished in recent years. In this context, ...
based inBoston, MASSACHUSETTS (USA)
SOPHiA GENETICS is the creator of a global data-sharing network – we work with customers from over 790 institutions in over 70 countries. Our network advances data-driven medicine to improve health outcomes and economics worldwide. We offer a ...
Next-generation sequencing (NGS) has the potential to revolutionize the diagnosis and treatment of cancers and rare diseases but creates extremely large, complex, and noisy datasets for analysis. Without the right analytical technology, ...
based inUppsala, SWEDEN
Olink Proteomics is a Swedish company dedicated to innovation, quality, rigor and transparency, providing outstanding products and services for human protein biomarker discovery. Our groundbreaking Olink panels for precision proteomics help ...
Towards a better understanding of cardiovascular disease and personalized medicine. The Cardiovascular II (CVD II) panel is a high-throughput, multiplex immunoassay enabling analysis of 92 CVD-related protein biomarkers across 96 samples ...
based inCambridge, MASSACHUSETTS (USA)
Foundation Medicine was founded in 2010 with a mission to bring deep molecular information to the point of care for every patient living with advanced cancer. We’re an essential partner to patients, physicians, researchers, and biopharma ...
Foundation Medicine matches patients to precision oncology trials based on genomic alterations, tumor type, and age. Our team of expert curators and genomicists helps facilitate awareness of genomically matched clinical trial options for your ...